The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants

被引:0
|
作者
Morup, Sara Bohnstedt [1 ]
Leung, Preston [1 ]
Reilly, Cavan [2 ]
Sherman, Brad T. [3 ]
Chang, Weizhong [3 ]
Milojevic, Maja [1 ]
Milinkovic, Ana [4 ]
Liappis, Angelike [5 ,6 ]
Borgwardt, Line [7 ]
Petoumenos, Kathy [8 ]
Paredes, Roger [9 ,10 ]
Mistry, Shweta S. [2 ]
Macpherson, Cameron R. [1 ,11 ]
Lundgren, Jens [1 ,12 ]
Helleberg, Marie [1 ,12 ]
Reekie, Joanne [1 ]
Murray, Daniel D. [1 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Rigshospitalet, Copenhagen, Denmark
[2] Univ Minnesota, Sch Publ Hlth, Div Biostat & Hlth Data Sci, Minneapolis, MN USA
[3] Lab Human Retrovirol & Immunoinformat, Frederick Natl Lab Canc Res, Frederick, MD USA
[4] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[5] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[6] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA
[7] Copenhagen Univ Hosp, Rigshosp, Rigshospitalet, Copenhagen, Denmark
[8] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia
[9] Hosp Univ Germans Trias i Pujol, Dept Infect Dis, Badalona, Spain
[10] Hosp Univ Germans Trias i Pujol, IrsiCaixa, Badalona, Spain
[11] Inst Roche, Boulogne Billancourt, France
[12] Copenhagen Univ Hosp, Rigshosp, Rigshospitalet, Copenhagen, Denmark
来源
AIDS RESEARCH AND THERAPY | 2024年 / 21卷 / 01期
基金
新加坡国家研究基金会;
关键词
HIV-1; Viral load; Pathway analysis; SKAT-O; Type; 1; interferon; Host genetics; HIV RNA LEVELS; GENOME; RARE; VARIANT; INFECTION; THERAPY; IMPACT; TESTS; HOST;
D O I
10.1186/s12981-024-00610-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Human genetic contribution to HIV progression remains inadequately explained. The type 1 interferon (IFN) pathway is important for host control of HIV and variation in type 1 IFN genes may contribute to disease progression. This study assessed the impact of variations at the gene and pathway level of type 1 IFN on HIV-1 viral load (VL). Methods Two cohorts of antiretroviral (ART) na & iuml;ve participants living with HIV (PLWH) with either early (START) or advanced infection (FIRST) were analysed separately. Type 1 IFN genes (n = 17) and receptor subunits (IFNAR1, IFNAR2) were examined for both cumulated type 1 IFN pathway analysis and individual gene analysis. SKAT-O was applied to detect associations between the genotype and HIV-1 study entry viral load (log10 transformed) as a proxy for set point VL; P-values were corrected using Bonferroni (P < 0.0025). Results The analyses among those with early infection included 2429 individuals from five continents. The median study entry HIV VL was 14,623 (IQR 3460-45100) copies/mL. Across 673 SNPs within 19 type 1 IFN genes, no significant association with study entry VL was detected. Conversely, examining individual genes in START showed a borderline significant association between IFNW1, and study entry VL (P = 0.0025). This significance remained after separate adjustments for age, CD4(+) T-cell count, CD4(+)/CD8(+) T-cell ratio and recent infection. When controlling for population structure using linear mixed effects models (LME), in addition to principal components used in the main model, this was no longer significant (p = 0.0244). In subgroup analyses stratified by geographical region, the association between IFNW1 and study entry VL was only observed among African participants, although, the association was not significant when controlling for population structure using LME. Of the 17 SNPs within the IFNW1 region, only rs79876898 (A > G) was associated with study entry VL (p = 0.0020, beta = 0.32; G associated with higher study entry VL than A) in single SNP association analyses. The findings were not reproduced in FIRST participants.<br /> Conclusion Across 19 type 1 IFN genes, only IFNW1 was associated with HIV-1 study entry VL in a cohort of ART-na & iuml;ve individuals in early stages of their infection, however, this was no longer significant in sensitivity analyses that controlled for population structures using LME.
引用
收藏
页数:14
相关论文
共 49 条
  • [21] Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
    Yan, Celine S.
    Hanafi, Imelda
    Kelleher, Anthony D.
    Carr, Andrew D.
    Amin, Janaki
    McNally, Leon P.
    Cunningham, Philip H.
    JOURNAL OF CLINICAL VIROLOGY, 2010, 49 (04) : 249 - 253
  • [22] Apoptosis of CD4(+) and CD19(+) cells during human immunodeficiency virus type 1 infection - correlation with clinical progression, viral load, and loss of humoral immunity
    Samuelsson, A
    Brostrom, C
    vanDijk, N
    Sonnerborg, A
    Chiodi, F
    VIROLOGY, 1997, 238 (02) : 180 - 188
  • [23] Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy
    Thiele, Rebecca-Jo
    Gruenhagel, Benjamin
    Muenchhoff, Maximilian
    Pujantell-Graell, Maria
    Jocham, Linda
    Duesedau, Arne
    Hennesen, Jana
    Hildebrandt, Heike
    Hagen, Sven Hendrik
    Sandfort, Deborah
    Bunders, Madeleine J.
    Keppler, Oliver T.
    Hoffmann, Christian
    Altfeld, Marcus
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (06) : 1781 - 1785
  • [24] Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection
    Stefic, Karl
    Novelli, Sophie
    Mahjoub, Nadia
    Seng, Remonie
    Molina, Jean-Michel
    Cheneau, Christine
    Barin, Francis
    Chaix, Marie-Laure
    Meyer, Laurence
    Delaugerre, Constance
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (11) : 1793 - 1797
  • [25] High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions
    Alvarez-Muñoz, MT
    Zaragoza-Rodríguez, S
    Rojas-Montes, O
    Palacios-Saucedo, G
    Vázquez-Rosales, G
    Gómez-Delgado, A
    Torres, J
    Muñoz, O
    ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (04) : 382 - 386
  • [26] Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: A decentralization pilot study
    Mine, Madisa
    Bedi, Keabetswe
    Maruta, Talkmore
    Madziva, Dignity
    Tau, Modiri
    Zana, Tatenda
    Gaolathe, Tendani
    Moyo, Sikhulile
    Seipone, Khumo
    Ndwapi, Ndwapi
    Essex, Max
    Marlink, Richard
    JOURNAL OF VIROLOGICAL METHODS, 2009, 159 (01) : 93 - 97
  • [27] Complex Interactions Between Human Immunodeficiency Virus Type-1, Sex, and Osteopontin Influence Viral Replication and Leukocyte Proportions in Tissues
    Mahmud, Farina J.
    Greif, Elizabeth
    Boucher, Thomas
    Pate, Kelly A. Metcalf
    Lyons, Claire
    Carlson, Bess
    Brown, Amanda M.
    FRONTIERS IN VIROLOGY, 2021, 1
  • [28] Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study
    Ulfhammer, Gustaf
    Eden, Arvid
    Antinori, Andrea
    Brew, Bruce J.
    Calcagno, Andrea
    Cinque, Paola
    De Zan, Valentina
    Hagberg, Lars
    Lin, Amy
    Nilsson, Staffan
    Oprea, Cristiana
    Pinnetti, Carmela
    Spudich, Serena
    Trunfio, Mattia
    Winston, Alan
    Price, Richard W.
    Gisslen, Magnus
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (03) : 493 - 502
  • [29] Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1
    K. Leriche-Guérin
    M. A. Trabaud
    L. Cotte
    F. Bissuel
    E. Deruelle
    P. Rougier
    C. Trépo
    European Journal of Clinical Microbiology and Infectious Diseases, 1997, 16 : 660 - 668
  • [30] Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana
    Abana, Christopher Z.
    Sagoe, Kwamena W. C.
    Bonney, Evelyn Y.
    Maina, Edward K.
    Aziati, Ishmael D.
    Agbosu, Esinam
    Mawuli, Gifty
    Styer, Linda M.
    Ishikawa, Koichi
    Brandful, James A. M.
    Ampofo, William K.
    MEDICINE, 2019, 98 (06)